Skip to content


You currently have no items in your basket.


ImmunoDiagnostics Limited (IMD) is a spin-off biotech company from The University of Hong Kong, and has R&D activities in both Toronto, Canada and Hong Kong. The founders of IMD are academic professoriates with strong research background in immunology, metabolism, cardiovascular medicine, and antibody and protein engineering. The company has over 12 years of experience in biomarker discovery and development of highly-specific immunoassays for both research & in vitro diagnostics (IVD) for major infectious diseases, cardiometabolic disorders and autoimmune diseases.

View All ImmunoDiagnostics Products
  • 100% guaranteed
  • Publications
  • Slave free alliance

About ImmunoDiagnostics

ImmunoDiagnostics has established state-of-the-art platforms for expression, purification and functional characterization of bioactive proteins from different sources (E. coli, yeast, insect cells and mammalian cells), generation and validation of both polyclonal and monoclonal antibodies, identification and cloning of genes encoding monoclonal antibodies specific to a target of interest using Next Generation Sequencing. Furthermore, our immunoassays have been validated in a large number of unique clinical biobanks in Asia, Europe and North America. Thus far, IMD has developed several hundreds of research products, including bioactive proteins, validated antibodies and immunoassays, which have been widely used in over 30 countries, such as the United States, Canada, United Kingdom, China, Australia and Singapore. IMD products have been cited by many publications in prestigious journals including Cell, Cell Metabolism, Nature Series, JCI, PNAS.